Clinical Trial Results:
A phase II, single-center, randomized, controlled, observer-blind study to determine the non-inferiority of a topical mometasone formulation vs a marketed comparator by evaluation of the anti-psoriatic efficacy in a psoriasis plaque test
Summary
|
|
EudraCT number |
2008-002141-24 |
Trial protocol |
DE |
Global completion date |
25 Jul 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
08 Jun 2016
|
First version publication date |
06 Jun 2015
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
2008-002141-24 study report synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.